May 02, 2024 / 09:00PM GMT
Operator
Good day, everyone, and welcome to the Lexicon Pharmaceuticals's first-quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded today, May 2, 2024.
I will now turn the call over to Lisa DeFrancesco, Head of Investor Relations and Strategy for Lexicon. Please go ahead, Lisa.
Lisa DeFrancesco - Lexicon Pharmaceuticals Inc - Head, Investor Relations and Strategy
Thank you, Jamie, and good afternoon and welcome to the Lexicon Pharmaceuticals's first-quarter 2024 financial results conference call. Joining me today are Lonnel Coats, Lexicon's Chief Executive Officer and Director; Jeff Wade, Lexicon's President and Chief Financial Officer; Dr. Craig Granowitz, Lexicon's Senior Vice President and Chief Medical Officer; and Tom Garner, Lexicon's Senior Vice President and Chief Commercial Officer.
Earlier this afternoon, Lexicon issued a press release announcing financial results for the first quarter of 2024, which is available on our website at
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot